Navigation Links
Ground-breaking study to cap the growing trend of type 2 diabetes in overweight adolescents
Date:6/1/2009

Researchers at The Children's Hospital at Westmead are embarking on a ground-breaking new study to investigate whether a different dietary approach to insulin resistance in overweight adolescents can put the brakes on its progression to type 2 diabetes.

Type 2 diabetes affects 85 to 90 per cent of all people with diabetes. While it usually affects mature adults, younger people and children are increasingly being diagnosed. Often people with type 2 diabetes also have high blood pressure, high cholesterol and are overweight or obese.

The MBF Foundation funded the three-year $400,000 project recognising increased medical and community concern about the growing number of overweight children being diagnosed with insulin resistance.

Currently adolescents with insulin resistance are managed through a combination of exercise, diet in line with the Australian Dietary Guidelines and medication, with the aim of preventing or delaying the onset of type 2 diabetes.

Clinicians at The Children's Hospital at Westmead are evaluating two diets, combined with an exercise program, for their effectiveness in turning the risk of this condition around. As a result of a growing body of evidence that amongst adults higher protein diets can more effectively reduce body fat and help control insulin levels, dietitians will investigate whether young people can similarly benefit from a high protein diet.

Dr Christine Bennett, MBF Foundation Steering Committee Chair and Chief Medical Officer of Bupa Australia*, says that one in four young Australians are now overweight or obese** and some of these will go on to develop type 2 diabetes if urgent action is not taken to manage this increasing problem.

"Type 2 diabetes can be difficult to control and needs to be managed effectively. Complications are often present at diagnosis and can lead to heart and kidney disease appear later in life. We can potentially save thousands of adolescents from this serious long term chronic condition," she said.

"We want to give our young people the best possible start to life and find the best way to help them deal with a difficult problem. With early intervention insulin resistance is potentially reversible, or at least the progression to type 2 diabetes can be delayed."

The program will see 108 adolescents aged between 10 and 18 take part in a diet and exercise regime.

Participants will follow one of two diets. The first will be based on the currently recommended Australian Guide to Healthy Eating, which is high in carbohydrates and low in fat. The second will follow a lower carbohydrate and increased protein diet.

"Teen-friendly diet models will be used to enhance compliance with the aim of reducing insulin levels and helping young participants lose weight," said Dr Sarah Garnett Principal Researcher from the Westmead Children's Hospital.

"We believe the project is the first of its kind. There is little evidence currently available to establish the best diet to control insulin resistance in adolescents and the role of protein in the diet,' said Dr Garnett. "This will tell us the advice we can give these kids that will actually work."

The program involves an intensive three month dietary intervention and a three month intensive gym and home based exercise program. The participants will be followed up for six months to measure the program's effectiveness.


'/>"/>

Contact: Jackie Crossman
jackie@crossmancommunications.com.au
61-293-610-519
Research Australia
Source:Eurekalert

Related medicine news :

1. Design-her Gals(TM) Announces the Ground-Breaking Virtual On-Line Walk for Wishes to Grant Dreams for Stage IV Breast Cancer Patients this Holiday Season Through Gal to Gal Foundation
2. On The Go Ships 100TB Hardware Order for Ground-Breaking Cancer Imaging and Therapy Projects
3. CEL-SCI CORPORATION Announces Results of 2008 Annual Meeting of Shareholders and Provides Update on Ground-breaking Activities Regarding Construction of Manufacturing Facility for Pivotal Phase III Cancer Trial
4. Ground-breaking new insight into the development of Alzheimers disease
5. Drumlin Security Launches Ground-breaking Low Cost PDF Publishing Service
6. Ground-breaking New Reality Show Hair Loss Confidential Launches First Webisode
7. Canada Supports Ground-Breaking Malaria Treatment Program in Sub-Saharan Africa
8. Cleveland Clinic Launches Ground-Breaking Wellness Program To Reverse Effects of Common Chronic Diseases
9. Bonus Footage From The Ground-breaking New Reality Show Hair Loss Confidential
10. Cleveland Clinic Launches Ground-Breaking Wellness Program To Reverse Effects of Common Chronic Diseases
11. Light of Hope: Help for Children with Autism Ground-Breaking Internet Television Event on April 24 to April 26 Co-Sponsored by Internet Software Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... WHO: , Dr. Paul ... , WHAT: , Medical doctors and PhD scientists will speak to the press on ... Trump in support of an independent vaccine safety commission. , WHERE: , Zenger ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Radiology Business Management Association (RBMA) ... as its new executive director. Mr. Still was selected through a careful months-long search ... as he is known to our members, has been a part of building the ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... physicians, Paul Yost, will begin serving as new board chair for Orange County ... Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s term, which ...
(Date:3/28/2017)... ... 28, 2017 , ... Neurotechnology , a provider of ... attendance tracking products: the new NCheck Cloud Bio Attendance cloud-based service and the ... face recognition to enable users to check in and out from anywhere via ...
(Date:3/28/2017)... MA (PRWEB) , ... March 28, 2017 , ... ... for direct measurement of corrosive ions found in power plant water and steam. ... components such as turbines and boilers, leading to extensive maintenance and unplanned shutdowns. ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... March 28, 2017  Orexigen Therapeutics, Inc. (Nasdaq: ... for the fourth quarter and year ended December 31, ... of transformational progress for Orexigen, beginning with the re-acquisition ... Commencing early March, the team at Orexigen demonstrated remarkable ... which reshaped and strengthened our Company while rewarding us ...
(Date:3/28/2017)... BOSTON , March 28, 2017  Market ... today announced a partnership with premium news content ... pharmaceutical companies to extract key insights from Dow ... mining technology. The Linguamatics I2E platform ... 20 global pharmaceutical companies. The Linguamatics-Dow Jones partnership ...
(Date:3/28/2017)... 28, 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... Medicines Agency (EMA) has notified the company that ... Authorisation Application (MAA) has passed validation, and that ... The MAA for ARX-04 (known as DSUVIA™ in ...
Breaking Medicine Technology: